Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Combining optimised Niaspan CF [extended-release nicotinic acid caplet formulation] with aspirin appears to be beneficial

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Kos Pharmaceuticals Inc.Kos Reports Summary Results from Clinical Study on Benefits of Combining Aspirin with Optimized Niaspan(R) CF. Media Release: 25 Jul 2006. Available from: URL: http://www.businesswire.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Combining optimised Niaspan CF [extended-release nicotinic acid caplet formulation] with aspirin appears to be beneficial. React. Wkly. 1113, 3 (2006). https://doi.org/10.2165/00128415-200611130-00009

    Download citation

    Keywords

    • Public Health
    • Aspirin
    • Nicotinic Acid
    • Niaspan
    • Provocation Study